AgingResearch.NewsJoin free

miR-873-5P inhibitor

miR-873-5P inhibitor has been studied in 1 paper since 2024: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Jan 23, 2024: “miR-873-5p Suppression Reinvigorates Aging Mesenchymal Stem Cells and Improves Cardiac Repair after Myocardial Infarction”.

Intervention

1 paper studies it1 findingUpdated

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funders: Government of Jiangsu Province and 4 more
  • Animals1

What did studies of miR-873-5P inhibitor find?

1

Studies of miR-873-5P inhibitor measured 1 outcome; the most studied are cellular senescence (1 study).

Cellular senescence

downin human cells1

1 study

  1. miR-873-5P inhibitor decreases cellular senescence in human cells.

    “reducing miR-873-5p expression decreased aging in AMSCs”

    Cellsin AMSCsmesenchymal stem cells

    miR-873-5p Suppression Reinvigorates Aging Mesenchymal Stem Cells and Improves Cardiac Repair after Myocardial Infarction

    ACS pharmacology & translational science

More on Cellular senescence

Latest

Related